The latest research study “Empty Capsules Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global empty capsules market reached a value of US$ 2.61 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 4.14 Billion by 2027 exhibiting a CAGR of 7.60% during 2022-2027.
Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/empty-capsules-market/requestsample
Empty capsules are stable shells used to enclose medications administered in the patient’s body in various dosage forms. They are usually formulated with gelatin and non-gelatin materials, including hydroxypropyl methylcellulose (HPMC), pullulan, and starch. The gelatin-based capsules are animal-based, made from pig meat, cattle, and chicken connective tissues and possess a high collagen content. Whereas, vegetarian or non-gelatin capsules, are prepared from starch and HPMC combination. They are widely used to store therapeutic drugs, powders, and herbs. As a result, empty capsules find extensive applications in treating illnesses, preparing dietary supplements, preventing common diseases, such as colds and coughs, and manufacturing antacids and antiflatulents.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Empty Capsules Market Trends and Drivers:
The global empty capsules market is primarily driven by a significant rise in the prevalence of cardiovascular and chronic diseases, especially among the geriatric population. In line with this, the development of capsule-in-capsule technology that ensures the gastrointestinal safety of patients who did not receive capsule medicine has catalyzed market growth.
Besides this, the surging adoption of non-gelatin capsules in the healthcare industry due to their moderate strength, clarity, and resistance to oil and fat has augmented the product demand. Moreover, extensive investments in research and development (R&D) projects for the introduction of innovative therapeutic drugs and pharmaceuticals are other major growth-inducing factors.
Additionally, the rising demand from manufacturers for immediate-release capsules to produce medicinal products, such as antibiotics, painkillers, dietary supplements, inhalers, antibacterial, and antiacids, is accelerating the product demand. Other factors, including a rise in demand for nutritional supplements, easy access to advanced treatment options, and a surge in capsule drug delivery forms, are also anticipated to propel the market growth.
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/empty-capsules-market
|Empty Capsules Market Report Scope|
|Market size value in 2021||US$ 2.61 Billion|
|Market forecast in 2027||US$ 4.14 Billion|
|Growth Rate||CAGR of 7.60% from 2022 to 2027|
|Base year for estimation||2021|
Global Empty Capsules Market 2022-2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
ACG Associated Capsules Pvt. Ltd., Bright Pharma Caps Inc., CapsCanada Corporation, HealthCaps India Limited, Lonza Group AG, Medicaps Limited, Qualicaps Co. Ltd. (Mitsubishi Chemical Holdings Corporation), Nectar Lifesciences Limited, Roxlor LLC, Shanxi Guangsheng Medicinal Capsules Co. Ltd, Snail Pharma Industry Co. Ltd, Suheung Co. Ltd and Sunil Healthcare Limited.
The report has segmented the market on the basis of region, type, raw material, functionality, therapeutic application and end user.
Breakup by Type:
- Gelatin Capsule
- Non-gelatin Capsule
Breakup by Raw Material:
- Pig Meat
- Bovine Meat
- Hydroxypropyl Methylcellulose (HPMC)
Breakup by Functionality:
- Immediate-release Capsules
- Sustained-release Capsules
- Delayed-release Capsules
Breakup by Therapeutic Application:
- Antibiotic and Antibacterial Drugs
- Vitamins and Dietary Supplements
- Antacid and Antiflatulent Preparations
- Cardiovascular Therapy Drugs
Breakup by End User:
- Pharmaceutical Industry
- Nutraceutical Industry
- Cosmetics Industry
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800